133 related articles for article (PubMed ID: 38497159)
1. Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation.
Hitawala AA; Gopalakrishna H; Mironova M; Livinski AA; Wright EC; Downing T; Ito S; Fisher SD; Cedars AM; John AS; Heller T
Aliment Pharmacol Ther; 2024 May; 59(9):1020-1032. PubMed ID: 38497159
[TBL] [Abstract][Full Text] [Related]
2. Fontan-associated liver disease: A review.
Gordon-Walker TT; Bove K; Veldtman G
J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
[TBL] [Abstract][Full Text] [Related]
3. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
[TBL] [Abstract][Full Text] [Related]
5. The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.
Sakamori R; Yamada R; Tahata Y; Kodama T; Hikita H; Tatsumi T; Yamada T; Takehara T
J Gastroenterol; 2022 Feb; 57(2):111-119. PubMed ID: 35064829
[TBL] [Abstract][Full Text] [Related]
6. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
[TBL] [Abstract][Full Text] [Related]
7. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for liver complications after the Fontan procedure.
Hilscher MB; Johnson JN; Cetta F; Driscoll DJ; Poterucha JJ; Sanchez W; Connolly HM; Kamath PS
Congenit Heart Dis; 2017 Mar; 12(2):124-132. PubMed ID: 28140526
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.
Nii M; Inuzuka R; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Ootsuki S; Kurita Y; Takeda A; Hirono K; Takei K; Yasukochi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
Circulation; 2021 Dec; 144(25):2043-2045. PubMed ID: 34928702
[No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
Possner M; Gordon-Walker T; Egbe AC; Poterucha JT; Warnes CA; Connolly HM; Ginde S; Clift P; Kogon B; Book WM; Walker N; Wagenaar LJ; Moe T; Oechslin E; Kay WA; Norris M; Dillman JR; Trout AT; Anwar N; Hoskoppal A; Broering DC; Bzeizi K; Veldtman G
Int J Cardiol; 2021 Jan; 322():142-148. PubMed ID: 32828959
[TBL] [Abstract][Full Text] [Related]
12. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
15. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up.
van Meer S; de Man RA; van den Berg AP; Houwen RH; Linn FH; van Oijen MG; Siersema PD; van Erpecum KJ
J Gastroenterol Hepatol; 2015 Mar; 30(3):535-9. PubMed ID: 25160780
[TBL] [Abstract][Full Text] [Related]
16. Liver Cirrhosis and Hepatocellular Carcinoma After the Fontan Operation: Reaching Clarity in the Face of Uncertainty.
Lam CZ; Gulamhusein A; Wald RM
Circulation; 2021 Dec; 144(25):1977-1980. PubMed ID: 34928704
[No Abstract] [Full Text] [Related]
17. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
Behari J; Gougol A; Wang R; Luu HN; Paragomi P; Yu YC; Molinari M; Chopra K; Malik SM; Geller D; Yuan JM
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37395730
[TBL] [Abstract][Full Text] [Related]
19. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
Lockart I; Yeo MGH; Hajarizadeh B; Dore GJ; Danta M
Hepatology; 2022 Jul; 76(1):139-154. PubMed ID: 35030279
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study.
Montes Ramírez ML; Miró JM; Quereda C; Jou A; von Wichmann MÁ; Berenguer J; González-García JJ; Hernando A; Ortega E; Sanz J; Arribas JR;
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):82-6. PubMed ID: 24419065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
